Elliott J. Mufson

 

Fields of interest:

Mechanisms underlying the selective vulnerability of neuronal populations which degenerate in people with mild cognitive impairment , Alzheimer's disease and Parkinson's disease

Recent publications:

Ginsberg S. D., Alldred M. J., Counts S. E., Cataldo A. M., Neve R. L., Jiang Y., Wuu J., Chao M. V., Mufson E. J., Nixon R. A., Che S.:
Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression
Biol. Psychiatry 2010; 68(10): 885-893.

Overk C. R., Felder C. C., Tu Y., Schober D. A., Bales K. R., Wuu J., Mufson E. J.:
Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease
J. Chem. Neuroanat. 2010; 40(1): 63-70.

Oh K. J., Perez S. E., Lagalwar S., Vana L., Binder L., Mufson E. J.:
Staging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis
Int. J. Alzheimers Dis. 2010; 2010.

Counts S. E., Mufson E. J.:
Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity
J. Neurochem. 2010; 113(3): 649-660.

Perez S. E., Berg B. M., Moore K. A., He B., Counts S. E., Fritz J. J., Hu Y. S., Lazarov O., Lah J. J., Mufson E. J.:
DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effects
J. Neurosci. Res. 2010; 88(5): 1026-1040.

Mufson E. J., Wuu J., Counts S. E., Nykjaer A.:
Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease
Neurosci. Lett. 2010; 471(3): 129-133.

Mufson E. J., Leurgans S.:
Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer's disease
Neurodegener. Dis. 2010; 7(1-3): 139-142.

Bruno M. A., Mufson E. J., Wuu J., Cuello A. C.:
Increased matrix metalloproteinase 9 activity in mild cognitive impairment
J. Neuropathol. Exp. Neurol. 2009; 68(12): 1309-1318.

Overk C. R., Kelley C. M., Mufson E. J.:
Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease
Neurobiol. Dis. 2009; 35(3): 415-425.

Peng S., Garzon D. J., Marchese M., Klein W., Ginsberg S. D., Francis B. M., Mount H. T., Mufson E. J., Salehi A., Fahnestock M.:
Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease
J. Neurosci. 2009; 29(29): 9321-9329.